Historical Valuation
Ironwood Pharmaceuticals Inc (IRWD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.02 is considered Undervalued compared with the five-year average of 14.28. The fair price of Ironwood Pharmaceuticals Inc (IRWD) is between 6.88 to 11.63 according to relative valuation methord. Compared to the current price of 3.98 USD , Ironwood Pharmaceuticals Inc is Undervalued By 42.11%.
Relative Value
Fair Zone
6.88-11.63
Current Price：3.98
42.11%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Ironwood Pharmaceuticals Inc (IRWD) has a current Price-to-Book (P/B) ratio of -2.63. Compared to its 3-year average P/B ratio of -1.84 , the current P/B ratio is approximately 42.56% higher. Relative to its 5-year average P/B ratio of 1.99, the current P/B ratio is about -232.10% higher. Ironwood Pharmaceuticals Inc (IRWD) has a Forward Free Cash Flow (FCF) yield of approximately 9.74%. Compared to its 3-year average FCF yield of 21.31%, the current FCF yield is approximately -54.30% lower. Relative to its 5-year average FCF yield of 17.90% , the current FCF yield is about -45.59% lower.
P/B
Median3y
-1.84
Median5y
1.99
FCF Yield
Median3y
21.31
Median5y
17.90
Competitors Valuation Multiple
AI Analysis for IRWD
The average P/S ratio for IRWD competitors is 9.07, providing a benchmark for relative valuation. Ironwood Pharmaceuticals Inc Corp (IRWD.O) exhibits a P/S ratio of 2.02, which is -77.68% above the industry average. Given its robust revenue growth of 33.26%, this premium appears sustainable.
Performance Decomposition
AI Analysis for IRWD
1Y
3Y
5Y
Market capitalization of IRWD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IRWD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is IRWD currently overvalued or undervalued?
Ironwood Pharmaceuticals Inc (IRWD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.02 is considered Undervalued compared with the five-year average of 14.28. The fair price of Ironwood Pharmaceuticals Inc (IRWD) is between 6.88 to 11.63 according to relative valuation methord. Compared to the current price of 3.98 USD , Ironwood Pharmaceuticals Inc is Undervalued By 42.11% .
What is Ironwood Pharmaceuticals Inc (IRWD) fair value?
IRWD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Ironwood Pharmaceuticals Inc (IRWD) is between 6.88 to 11.63 according to relative valuation methord.
How does IRWD's valuation metrics compare to the industry average?
The average P/S ratio for IRWD's competitors is 9.07, providing a benchmark for relative valuation. Ironwood Pharmaceuticals Inc Corp (IRWD) exhibits a P/S ratio of 2.02, which is -77.68% above the industry average. Given its robust revenue growth of 33.26%, this premium appears sustainable.
What is the current P/B ratio for Ironwood Pharmaceuticals Inc (IRWD) as of Jan 09 2026?
As of Jan 09 2026, Ironwood Pharmaceuticals Inc (IRWD) has a P/B ratio of -2.63. This indicates that the market values IRWD at -2.63 times its book value.
What is the current FCF Yield for Ironwood Pharmaceuticals Inc (IRWD) as of Jan 09 2026?
As of Jan 09 2026, Ironwood Pharmaceuticals Inc (IRWD) has a FCF Yield of 9.74%. This means that for every dollar of Ironwood Pharmaceuticals Inc’s market capitalization, the company generates 9.74 cents in free cash flow.
What is the current Forward P/E ratio for Ironwood Pharmaceuticals Inc (IRWD) as of Jan 09 2026?
As of Jan 09 2026, Ironwood Pharmaceuticals Inc (IRWD) has a Forward P/E ratio of 6.83. This means the market is willing to pay $6.83 for every dollar of Ironwood Pharmaceuticals Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Ironwood Pharmaceuticals Inc (IRWD) as of Jan 09 2026?
As of Jan 09 2026, Ironwood Pharmaceuticals Inc (IRWD) has a Forward P/S ratio of 2.02. This means the market is valuing IRWD at $2.02 for every dollar of expected revenue over the next 12 months.